LBA-001 - Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial

Autor: Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M., Park, J., Hochhauser, D., Arnold, D., Oh, D., Reinacher-Schick, A., Tortora, G., Algül, H., O’Reilly, E., McGuinness, D., Cui, K., Schlienger, K., Locker, G., Kindler, H.
Zdroj: In Annals of Oncology July 2019 30 Supplement 4:iv152-iv152
Databáze: ScienceDirect